Is Mind Medicine Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: MNMD) stock is to Strong Buy MNMD stock.
Out of 3 analysts, 1 (33.33%) are recommending MNMD as a Strong Buy, 2 (66.67%) are recommending MNMD as a Buy, 0 (0%) are recommending MNMD as a Hold, 0 (0%) are recommending MNMD as a Sell, and 0 (0%) are recommending MNMD as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year MNMD price target, the average MNMD price target is $33.67, with the highest MNMD stock price forecast at $75.00 and the lowest MNMD stock price forecast at $5.00.
On average, Wall Street analysts predict that Mind Medicine's share price could reach $33.67 by Mar 16, 2024. The average Mind Medicine stock price prediction forecasts a potential upside of 1,056.94% from the current MNMD share price of $2.91.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.